The effects of intraperitoneal (IP) administration of the endogenous opioid peptide, [Leu1enkephalin (LE), on avoidance conditioning in rodents were investigated. At a dose of 30 /lglkg (IP), LE enhanced acquisition of a one-way step-through active avoidance response when administered 2 minutes before training to Swiss Webster mice. [Leu1enkephalin produced aU-shaped dose-response function because both lower and higher doses of LE did not affect avoidance responding. fLeu1enkephalin-induced enhancement of avoidance ac quisition was also observed in Sprague-Dawley rats; the intraperitoneal injection of 10 /lglkg LE, administered 5 minutes before training, enhanced acquisition of a tinez et al. 1991a; Koob 1987; Gold 1989; McGaugh 1989) . Two of these defming characteristics are that 1) the dose-response functions produced by modulatory substances are V-shaped, rather than hyperbolic, and 2) each modulatory substance has the ability to either
In 1981, McGaugh and Martinez designated neurohor manes that affect learning and memory as learning modulatory hormones. Since that time, empirical re search has determined the defming characteristics of endogenous substances that modulate learning (Mar tinez et al. 1991a; Koob 1987; Gold 1989; McGaugh 1989) . Two of these defming characteristics are that 1) the dose-response functions produced by modulatory substances are V-shaped, rather than hyperbolic, and 2) each modulatory substance has the ability to either jump-up one-way active avoidance response. When administered to Sprague-Dawley rats immediately after training, LE (30 /lglkg IP) enhanced jump-up avoidance responding at test 24 hours after peptide injection. Previously, we found LE to impair acquisition in the same tasks in both rats and mice, also at microgram doses, and also in a U-shaped manner. Thus, LE can either enhance or impair learning within the same species and the same task; these findings are in agreement with recent theoretical proposals regarding the nature of compounds, such as LE, that modulate learning and memory. [Neuropsychopharmacology 10:53-60, 19941 improve or worsen learning and memory (Martinez et al. 1991a; Schulteis and Martinez 1992a; Gold 1989) . These characteristics are derived from discovering commonalities among the consider able list of endogenous hormones that influence learned performance in experimental animals.
Opioid peptides, such as �-endorphin, dynorphin,
[Met]enkephalin (ME), and [Leu]enkephalin (LE), are endogenous neuropeptides that appear to be learning and memory modulatory substances. For each of these opioid peptides, the characteristic V-shaped dose-effect function has been demonstrated (for examples, see Mar tinez et al. 1981 Mar tinez et al. , 1991a Schulteis et al. 1988; Colombo et al. 1992; Martinez and Rigter 1980) , thus fulfIlling the fIrst of the defIning characteristics for a modulatory sub stance.
The second defIning characteristic of bidirectional memory effects of modulatory substances is less clear for these opioid peptides. For example, the endogenous opioid peptide LE, when administered to a variety of species in a multitude of tasks, most frequently impairs learning (Rigter et al. 1980a (Rigter et al. , 1980b 0893-133X/94/$7.00 al. 1980; Izquierdo and Dias 1981; Martinez et al. 1981 Martinez et al. , 1984 Martinez et al. , 1985a Martinez et al. , 1985b Martinez et al. , 1988 Martinez et al. , 1990 Martinez and Rigter 1982; Introini et al. 1985; Dana and Martinez 1986; Lin den and Martinez 1986; Schulteis et al. 1988 Pat terson et al. 1989; Janak and Martinez 1990; Sandi et al. 1990; Schulteis and Martinez 1992b) .
[Leu]enkepha lin impairs active avoidance acquisition in mice (Marti nez et al. 1985b; Dana and Martinez 1986; Janak and Martinez 1990 ) and in rats (Rigter et al. 1980a (Rigter et al. , 1980b Martinez and Rigter 1982; Mar tinez et al. 1985a ).
[Leu]enkephalin also impairs reten tion of active avoidance conditioning in mice (Dana and Martinez 1986 ; Schulte is and Martinez 1992b) and rats (Izquierdo et al. 1980; Izquierdo and Dias 1981) .
In contrast, some studies report that LE enhances learning and memory.
[Leu]enkephalin attenuates C02-induced amnesia for a passive avoidance response in rats (Rigter 1978) and enhances retention of a passive avoidance response in rats . Thus, a small number of studies suggest that LE enhances learning and memory in animals.
As with LE, the most frequently observed effect of exogenous administration of other opioid peptides is learning and memory impairment (see Martinez et al. 1991a for review), although a few cases of enhancement were observed. For example, al though ME is reported to impair acquisition (Rigter et al. 1980a ) and retention (Introini et al. 1985; Izquierdo and Dias 1981) of avoidance conditioning in rats and mice, other reports indicate that ME enhances acquisi tion of Y-maze (Martinez et al. 1984 ) and complex maze (Kastin et al. 1976 ) learning and delays extinction of a pole-jump response (de Wied et al. 1978 ) in rats.
[Met]enkephalin also enhances retention of and attenu ates C02-induced amnesia for passive avoidance con ditioning in rats Rigter 1978) . Because the methodologies (task and injection route; strain and species used) varied between these studies of the learning and memory effects of enkepha lins, it is difficult to directly compare the results. Thus, the evidence indicates that some enkephalins either en hance or impair learned behavior; however, it has yet to be demonstrated that enkephalins are capable of producing enhancement and impairment under the same conditioning parameters. The following studies demonstrate that the pre-or posttraining intraperitoneal injection of LE enhances active avoidance condition ing in two separate species; in each case, the task parameters were identical to those in which we have previously demonstrated LE-induced learning impair ment Oanak and Martinez 1990; Weinberger et al. 1989 ).
This demonstration supports current views that the be havioral effect of an exogenously administered opioid may depend upon the basal state of the subject, rather NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO. 1 than task parameters alone (Martinez et al. 1991a; Schulteis and Martinez 1992a) .
GENERAL METHODS

Subjects
Food and water were available ad lib; the animals were maintained on a standard 12-hour lightll2-hour dark schedule with lights on at 7 A.M. Newly arrived animals were allowed at least 4 days to acclimate before any ex perimental procedures were conducted. Housing con ditions were in accord with National Institutes of Health (NIH) guidelines, and all experimental procedures were approved in advance by the Animal Care and Use Com mittee at the University of California, Berkeley.
Drugs
[Leu ]enkephalin (Tyr-Gly-Gly-Phe-Leu), obtained from Bachem (Torrance, CA), was dissolved in 0.9% saline and administered via intraperitoneal injection in a vol ume of 1 mlllOO g for mice and 1 mIl kg for rats. The experimenter was unaware of the specifIc treatment a subject received until testing was concluded.
Procedures
The subjects were brought into the testing room a mini mum of 3 hours before conditioning began. All ex perimental procedures occurred between the hours of 11 AM and 4 PM. A tensor lamp provided dim lighting, and a fan provided background noise.
Data Analysis
Planned single degree-of-freedom comparisons be tween the treatment (LE-injected) and control (vehicle injected) groups were conducted. To control for Type I error, the Bonferroni correction method was applied to adjust the alpha level for each experiment (Keppel 1991) ; family-wise error was set to .10. Because a limited number of animals may be used in each day's study, completion of a full dose-response curve required com bining data across consecutive experimental days. Be cause a saline-injected control group was included in each experimental session, pooling of the saline-treated subjects created a larger sample size in the saline-treated groups than in the drug-treated groups. 10-�g/kg LE, n = 9; 30-�g/kg LE, n = 13; 100-�g/kg LE, n = 19; 300-�g/kg, n = 5. *p < .05.
EXPERIMENT 1
This experiment investigated the effect of pre training LE administration on one-way step-through active avoidance conditioning in mice.
Methods
Subjects. Male Swiss Webster mice, weighing be tween 29 and 36 g, were obtained from Benton-King man and were housed three to a cage.
Apparatus and Procedure. The avoidance chamber consisted of two trough-shaped compartments: a smaller we ll-lit compartment (10 x 10 x 10 cm), made of white ac rylic, separated by a black acrylic sliding door from a metal-floored shock compartment. The shock com partment (23 x 10 x 10 cm) was constructed of black acrylic, except for the metal floor. Peptide (10, 30, 100, or 300 Ilg/kg) or saline was administered 2 minutes prior to avoidance training. On the ti.rst trial, animals were placed in the shock compartment facing away from the closed entrance to the lit compartment. After 10 sec onds, the doorway separating the two compartments was opened and the animals received a mild footshock All subjects completed training and were included in the ti.nal analysis of the data.
Results
Pre training LE enhanced acquisition of one-way active avoidance responding in mice. As seen in Figure 1 
EXPERIMENT 2
This experiment investigated the effects of pre training LE administration on acquisition of active avoidance responding in rats. The task used differs from the step through active avoidance task in that a distinctive con ditioned stimulus (CS) (houselight) signals the uncon ditioned stimulus (US) (footshock), and jumping, rather than forward locomotion, is required for shock escape or avoidance. In addition, the jump-up avoidance ap paratus is automated, thus eliminating the need for in tertrial experimenter handling, as required by the step through one-way avoidance apparatus.
Methods
Subjects. Male Sprague-Dawley rats, weighing be tween 260 and 300 g, were obtained from Simonsen and were singly housed. depositing the rat onto the steel-rod floor and initiat ing the next trial. For the following 7 trials, the plat form was exposed and the CS came on 10 seconds prior to footshock (US) onset; therefore, the subject could avoid footshock by jumping onto the exposed platform prior to shock initiation. Maximum trial length was 40 seconds. Subjects that did not escape the footshock for two or more trials were excluded from the study (5%); exclusion was uniform across treatment groups. 
EXPERIMENT 3
The previous two experiments demonstrated that the pretraining injection of LE enhances avoidance re sponse acquisition. This experiment investigated the effects of posttraining LE injection on jump-up avoid ance responding in a 3-day paradigm in rats.
Methods
Subjects. Male Sprague-Dawley rats, weighing be tween 230 and 280 g, were obtained from Harlan Sprague-Dawley and were singly housed.
Apparatus and Procedure. The apparatus was the same as that used in Experiment 2. Conditioning con sisted of three consecutive daily sessions. On day 1, each rat was given one escape-only trial in which the CS (houselight) onset and footshock (US) (290 IlA) on set were paired for 30 seconds or until the subject jumped up onto the platform, thus terminating the CS and the shock. Each subject was then removed from the apparatus, injected with LE (3 or 30 Ilg/kg) or vehi cle, and replaced into its home cage. The procedure on day 2 was exactly the same as on day 1. On day 3, each rat received 12 trials in which the shelf was exposed 10 seconds prior to footshock onset, allowing the sub ject to either avoid or escape the shock, as described in Experiment 2. Subjects that did not learn the escape response on day 1 or 2 were excluded from the study (10%); exclusion was uniform across treatment groups.
Results
The results indicated that 2 days of posttraining LE ad (Rigter et a1. 1980a (Rigter et a1. , 1980b (Rigter et a1. , 1981 Martinez and Rig ter 1982; Martinez et a1. 1985a ) and mice (Martinez et aI. 1985b; Dana and Martinez 1986; Schulteis et aI. 1988; Janak and Martinez 1990) , these results show that LE can both enhance and impair acquisition of active avoid ance conditioning. Importantly, the enhancement of avoidance responding produced by LE in this study was The second similarity between LE-produced learn ing enhancement and impairment is that the dose response functions produced in both cases are V shaped. Thus, we found that a dose of 30 �g/kg LE en hanced acquisition in mice, whereas doses both lower and higher had no effect. This quadratic-shaped dose response function, although opposite in direction, also is produced in experiments in which LE impairs avoid ance conditioning (Martinez et a1. 1988; Schulteis et a1. 1988 ). V-shaped, dose-response curves commonly are produced by treatments that modulate learning and memory, whether they are enhancing or impairing (see Martinez et a1. 1991a; Schulteis and Martinez 1992a for discussion of V-shaped curves and memory). There fore, at least in mice, the conditioning enhancement and impairment produced by LE are similar to one another.
The LE dose-response functions obtained in rats in the present study were not extended beyond the doses found to signifIcantly affect avoidance responding and therefore cannot lend support to these results obtained in mice.
Our results are similar to the effects of the endoge nous opioid peptides ME and p-endorphin on learn ing. Although some studies report impairment of aver sive conditioning Rigter 1980, 1982; Izquierdo et aI. 1980; Zhang et aI. 1987) , others report enhancement (de Wied et al. 1978; Martinez et al. 1984) . None of these studies in which I)-endorphin or ME enhanced learning and memory are easily compared to those studies in which the peptides produced impairment, as the studies did not use identical training and testing procedures. For example, I)-endorphin impaired reten tion of an inhibitory avoidance response when admin istered intra peritoneally to rats in a study by Martinez and Rigter (1980) , whereas subcutaneous administra tion of the same peptide enhanced rats' retention for an inhibitory avoidance response in a study by . It is notable that the studies reported here were conducted identically to previous studies in which we found LE to impair learning and memory.
What factors might have contributed to the results obtained in the present study? These results are not due to circadian or seasonal effects, because the time of day and year that testing occurred is similar to that of studies in which LE-induced impairment was observed previ ously by us in both rats and mice. In addition, the results of additional studies conducted by the experimenters indicate that the present results cannot be attributed to differences in experimenter handling. Indeed, the automated shelf-jump avoidance apparatus used for Ex periments 1 and 2 minimized experimenter handling.
However, although the avoidance acquisition en hancement observed in Experiment 1 was conducted in Swiss Webster mice, the strain of mice that we com monly use, the subjects came from a different commer cial breeder than used by us in previous studies. In fact,
we observed that the saline-treated mice included in Experiment 1 performed more poorly than saline-treated mice from some other breeders. Factors that lead to op posite effects in the same strain, but different suppliers,
are not known at this time. The albino rat subjects used for Experiments 2 and 3 were obtained from the same breeders we commonly use; however, the subjects were housed and the experiments were conducted in a differ ent building than used by us in previous studies. How different buildings contribute to opposite pharmaco logic effects is unknown. However, when compared to saline-treated subjects in our previous study of opioid effects on jump-up avoidance acquisition (Weinberger et al. 1989) , the saline-treated rats from Experiment 2 performed more poorly, suggesting that basal arousal levels of rats in the present studies may have been affected by the housing environment.
The present study thus suggests that determina tion of the overall direction of effect of a given phar macologic treatment is complex. Previous research with the classic learning and memory modulatory treatments, adrenocorticotrophic hormone (ACTH) and epineph rine, specifIed variables that may impact the direction of the effect of pharmacologic treatments on learning NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO.1 and memory. In the studies of Gold and van Buskirk (1975, 1976) (Schulteis and Martinez 1992a; Martinez et al. 1991a Martinez et al. , 1991b McCarty and Gold 1981; Gold 1989; McGaugh 1989) .
[Leu]enkephalin is similar to ACTH and epineph rine in that it is a hormonelike substance that is released into the circulation in response to arousal or stress (DiGiulio et al. 1978; Hanbauer et al. 1982; Hexum et al. 1980; Schultzberg et al. 1978) , and it alters learned performance. Thus, as with ACTH and epinephrine, factors that influence the arousal of experimental sub jects may alter the effects of exogenous administration of LE. Factors that were not explicitly manipulated in our studies, such as the commercial supplier and the housing envir.onment, could have been important de terminants of stress levels in our subjects. Thus, one possibility is that the basal arousal state (and, thus, the basal levels of endogenous circulating LE) of our sub jects helped determine the direction of effect of LE on avoidance conditioning. Interestingly, direct evidence that stress affects memory via an opioid-dependent mechanism is provided by the fInding that posttrain ing restraint stress strain-specifIcally alters retention of passive avoidance conditioning in mice, and these effects are reversed by naloxone (Castellano and Puglisi Allegra 1983 ).
The present results in which the endogenous opi oid peptide LE enhances learning, together with the more typical previous results in which LE impairs learn ing, provide evidence that fulfIlls both defIning char acteristics of a learning modulatory substance, as fIrst described by McGaugh and Martinez (1981) and later extended (Martinez et al. 1991a; Schulteis and Marti nez 1992a) . Thus, LE can either enhance or impair learn ing and memory, independent of task specifIcs such as the response requirement or the route of peptide ad ministration, and the function produced by LE adminis tration is U shaped, regardless of whether the peptide is enhancing or impairing behavior. Therefore, LE pro vides a good example of learning and memory modu lation by endogenous neuropeptides.
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